pharma · Irritable Bowel Syndrome With Constipation · Chronic Constipation · IRWD
IRONWOOD PHARMACEUTICALS
IRONWOOD PHARMACEUTICALS INC
IRONWOOD PHARMACEUTICALS is a pharma organization headquartered in Boston, USA. It trades on NYSE under ticker IRWD. Primary therapeutic focus areas include Irritable Bowel Syndrome With Constipation, Chronic Constipatio
100 Summer Street, Boston, MA 02110, US HQ
1998 Founded
262 Employees
Public company Type
IRWD · NYSE Ticker
Company details
- Status
- Public
- HQ
- 100 Summer Street, Boston, MA 02110, US
- Founded
- 1998
- Employees
- 262
- Programs
- 33
- Drugs
- 11
- Patents
- 45
Linaclotide or Matching Placebo
Phase 3 · small molecule · Irritable Bowel Syndrome With Constipation
Linaclotide or Matching Placebo for Irritable Bowel Syndrome With Constipation is a Phase 3 program (small_molecule) at IRONWOOD PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Internal code MCP-103-302
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- IRONWOOD PHARMACEUTICALS INC
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Irritable Bowel Syndrome With Constipation
- Status
- completed
- Trials
- 1